Toxicity and biodistribution of activated and non-activated intravenous iron oxide nanoparticles

J. A. Tate; J. A. Ogden; R. R. Strawbridge; Z. E. Pierce; P. J. Hoopes

doi:10.1117/12.809830

12 February 2009 Toxicity and biodistribution of activated and non-activated intravenous iron oxide nanoparticles

J. A. Tate, J. A. Ogden, R. R. Strawbridge, Z. E. Pierce, P. J. Hoopes

Proceedings Volume 7181, Energy-based Treatment of Tissue and Assessment V; 71810L (2009) https://doi.org/10.1117/12.809830
Event: SPIE BiOS, 2009, San Jose, California, United States

Abstract

The use of nanoparticles in medical treatment has prompted the question of their safety. In this study, the pathophysiology and biodistribution of three different concentrations of intravenously-delivered dextran-coated Fe3O4 iron oxide nanoparticles (IONP) were evaluated in mice. Some groups of mice were exposed to an AC magnetic field (AMF) at levels comparable with those proposed for cancer treatments. Iron biodistribution analysis for both AMF and non-AMF treated mice was performed for all three concentrations used (.6 mg Fe/mouse, 1.8 mg Fe/mouse, and 5.6 mg Fe/mouse). Blood urea nitrogen, alanine transaminase, alkaline phosphatase, total serum protein, and creatinine were also assessed at 4 hours, 7 days, and 14 days post-injection. Histological analysis of lung, spleen, heart, liver, and kidney tissue was conducted at 7 and 14 days post-injection. Prussian blue and H&E stains were used to histomorphometrically assess iron content in the tissues studied. Preliminary results demonstrate small temporary elevation in liver enzymes and hepatocyte vacuolization at all iron concentrations studied. Liver and spleen were the primary sites of IONP deposition. None of the animals demonstrated systemic or local toxicity or illness, with or without AMF activation.

Citation Download Citation

J. A. Tate, J. A. Ogden, R. R. Strawbridge, Z. E. Pierce, and P. J. Hoopes "Toxicity and biodistribution of activated and non-activated intravenous iron oxide nanoparticles", Proc. SPIE 7181, Energy-based Treatment of Tissue and Assessment V, 71810L (12 February 2009); https://doi.org/10.1117/12.809830

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available